Study of genetic and metabolic diseases in children
Part of Genetic & congenital, Hormones & metabolism clinical trials.
This study looks at children who may have genetic (inherited) or metabolic (body chemistry) problems, including newborn screening and episodes of trouble. The goal is to better understand these conditions and identify children who may benefit from further care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- For the newborn group: your child must be 1–2 days old
- For the newborn group: pregnancy age (gestational age) must be 37–42 weeks
- For the newborn group: your baby should be stable and in the normal newborn nursery
- For the older-child group: your child must be between 0 and 18 years old, but not already known to have a genetic/metabolic disease
- If joining the “diseased child” group: there must be signs like confirmed/suspected genetic or metabolic disease, unexplained episodes, or concerning developmental or birth findings
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study quickly reads a child’s DNA using whole genome sequencing to look for genetic causes of symptoms. It may help families and doctors better understand an underlying genetic condition and guide medical care.
This study collects and stores DNA samples and related health information from people of all ages. It helps researchers understand childhood diseases better and may support future discoveries and treatments.
This study uses a simple blood spot and urine test to look for chemical signs of rare metabolic diseases. It aims to improve early detection and understanding of these conditions across all ages, including healthy individuals.
This study evaluates children (and sometimes relatives) who may have hormone (endocrine) or metabolism-related conditions. It helps doctors better understand these problems by doing a clinical evaluation.
This study looks at using rapid DNA testing (genomics) in newborns and children who are very sick in the hospital (NICU or PICU). The goal is to see if finding a genetic cause early can help guide treatment and improve outcomes.
This trial uses genetic testing to better understand the cause of a newborn’s birth defect and to help doctors choose more personalized treatment. It may help families get clearer answers and more targeted care.
Hear when a new Genetic Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.